Get the Stockscreener App
37.72
1.59%
-0.61
After Hours:
37.71
-0.010
-0.03%
Vtv Therapeutics Inc stock is traded at $37.72, with a volume of 38,647.
It is down -1.59% in the last 24 hours and up +13.34% over the past month.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.
See More
Previous Close:
$38.33
Open:
$38.24
24h Volume:
38,647
Relative Volume:
0.88
Market Cap:
$148.57M
Revenue:
$17,000
Net Income/Loss:
$-31.08M
P/E Ratio:
-11.27
EPS:
-3.3463
Net Cash Flow:
$-24.86M
1W Performance:
-1.92%
1M Performance:
+13.34%
6M Performance:
+68.32%
1Y Performance:
+103.01%
1-Day Range:
$37.27
$38.50
1-Week Range:
$35.04
$39.15
52-Week Range:
$14.00
$44.00
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
37.72 | 150.97M | 17,000 | -31.08M | -24.86M | -3.3463 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Initiated | Evercore ISI | Outperform |
| Jan-23-26 | Initiated | Roth Capital | Buy |
| Jan-05-26 | Initiated | TD Cowen | Buy |
| Nov-19-25 | Initiated | BTIG Research | Buy |
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Liquidity Mapping Around (VTVT) Price Events - Stock Traders Daily
BTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target By Investing.com - Investing.com Canada
Sentiment Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Sector Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
Investment Review: Will vTv Therapeutics Inc benefit from green energy policiesPortfolio Performance Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Published on: 2026-04-11 18:49:35 - baoquankhu1.vn
Market Leaders: Whats next for vTv Therapeutics Inc stock2026 Analyst Calls & Consistent Profit Alerts - baoquankhu1.vn
VTVT Technical Analysis | Trend, Signals & Chart Patterns | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Aug Shorts: Will vTv Therapeutics Inc face regulatory challengesDividend Hike & Weekly Market Pulse Updates - baoquankhu1.vn
VTV Therapeutics (VTVT) reports $27M 2025 net loss amid cadisegliatin advancements - MSN
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Sahm
New vTv hire gets 4,000 stock options priced at $39.54 - Stock Titan
VTVT Forecast, Price Target & Analyst Ratings | VTV THERAPEUTICS INC- CL A (NASDAQ:VTVT) - ChartMill
Growth Recap: Will vTv Therapeutics Inc outperform the market in YEAR2026 Short Interest & Smart Money Movement Tracker - baoquankhu1.vn
We're Not Worried About VTv Therapeutics' (NASDAQ:VTVT) Cash Burn - Moomoo
We Think vTv Therapeutics (NASDAQ:VTVT) Can Easily Afford To Drive Business Growth - Sahm
Why (VTVT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet - sharewise.com
Millennium Management LLC Acquires Shares in vTv Therapeutics Inc - GuruFocus
VTVT Technical Analysis & Stock Price Forecast - Intellectia AI
Aug PostEarnings: How does vTv Therapeutics Inc score in quality rankingsStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
vTv Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Analysts’ Opinions Are Mixed on These Healthcare Stocks: vTv Therapeutics (VTVT) and CSPC Pharmaceutical Group (OtherCHJTF) - The Globe and Mail
Millennium Management (NASDAQ: VTVT) reports a 5.0% holding in vTv - Stock Titan
Technical Analysis: Will vTv Therapeutics Inc outperform the market in YEAR2026 EndofMonth & Long Hold Capital Preservation Plans - baoquankhu1.vn
How CRH plc stock performs during market volatility - baoquankhu1.vn
Aug Action: Does vTv Therapeutics Inc have declining or rising EPSEarnings Recap Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CEO Moves: Is vTv Therapeutics Inc exposed to currency risks2026 Key Highlights & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Understanding Momentum Shifts in (VTVT) - Stock Traders Daily
Guidance Update: Will vTv Therapeutics Inc benefit from green energy policiesInsider Selling & Real-Time Buy Zone Alerts - baoquankhu1.vn
Published on: 2026-03-23 05:09:08 - baoquankhu1.vn
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements - Yahoo Finance
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade - Yahoo Finance
vTv Therapeutics to Participate in the 38th Annual ROTH Conference - The Manila Times
VTv Therapeutics to Participate in the 38th Annual ROTH Conference - marketscreener.com
Biotech developing oral type 1 diabetes drug joins ROTH investor event - Stock Titan
Baker BROS. Advisors LP Has $3.46 Million Holdings in vTv Therapeutics Inc. $VTVT - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Upgraded at Evercore - MarketBeat
Wall Street Zen Upgrades vTv Therapeutics (NASDAQ:VTVT) to "Hold" - MarketBeat
HC Wainwright Raises Earnings Estimates for vTv Therapeutics - Defense World
HC Wainwright Brokers Increase Earnings Estimates for VTVT - Defense World
HC Wainwright Forecasts Higher Earnings for vTv Therapeutics - MarketBeat
This Jabil Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Sahm
Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT) and Oxford BioMedica (OtherOXBDF) - The Globe and Mail
Evercore ISI initiates vTv Therapeutics stock with outperform rating By Investing.com - Investing.com Canada
Evercore ISI Initiates vTv Therapeutics at Outperform With $44 Price Target - marketscreener.com
Evercore ISI Initiates Coverage on VTVT with Outperform Rating | VTVT Stock News - GuruFocus
Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Sarepta Therapeutics (SRPT) and vTv Therapeutics (VTVT) - The Globe and Mail
Research Analysts Set Expectations for VTVT Q1 Earnings - MarketBeat
vTv Therapeutics (NASDAQ:VTVT) Share Price Crosses Below 50-Day Moving AverageShould You Sell? - MarketBeat
BTIG Maintains Buy on vTv Therapeutics Inc (VTVT) March 11, 2026 - Meyka
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):